Literature DB >> 1890221

New views on periodontal microbiota in special patient categories.

J Slots1, T E Rams.   

Abstract

The microorganisms in periodontitis of special patient categories have been only partially elucidated. The periodontitis microbiota of HIV-infected individuals, cancer patients on myelosuppressive therapy, and persons with other medical disorders includes common suspected periodontal pathogens as well as enteric rods, pseudomonads, staphylococci and yeasts. Failing implants also may be associated with classical periodontal pathogens as well as primarily nonoral potential pathogens. Refractory periodontitis in systemically healthy adults can show a great variety of oral and nonoral organisms. The frequent occurrence of unusual periodontal organisms in special patient categories may be due to a weakened host response and/or usage of various chemotherapeutic regimens. The unusual organisms may contribute to progressive periodontitis and in leukemia patients may even give rise to life-threatening systemic manifestations. The primary therapeutic goal in special periodontitis patients is control of pathogens and amid the wide range of pathogenic microfloras, an effective treatment strategy should include a comprehensive microbiological analysis, especially if systemic antimicrobial therapy is contemplated.

Entities:  

Mesh:

Year:  1991        PMID: 1890221     DOI: 10.1111/j.1600-051x.1991.tb02309.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  21 in total

Review 1.  When human cells meet bacteria: precision medicine for cancers using the microbiota.

Authors:  Han Zhang; Litao Sun
Journal:  Am J Cancer Res       Date:  2018-07-01       Impact factor: 6.166

Review 2.  The Impact of Incorporating Antimicrobials into Implant Surfaces.

Authors:  N J Hickok; I M Shapiro; A F Chen
Journal:  J Dent Res       Date:  2017-09-18       Impact factor: 6.116

3.  Microbial diversity of supra- and subgingival biofilms on freshly colonized titanium implant abutments in the human mouth.

Authors:  W Heuer; M Stiesch; W R Abraham
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-10-08       Impact factor: 3.267

4.  Identification of Bacteroides forsythus in subgingival plaque from patients with advanced periodontitis.

Authors:  H Gersdorf; A Meissner; K Pelz; G Krekeler; U B Göbel
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

Review 5.  The Oral Microbiome of Children: Development, Disease, and Implications Beyond Oral Health.

Authors:  Andres Gomez; Karen E Nelson
Journal:  Microb Ecol       Date:  2016-09-14       Impact factor: 4.552

6.  Periodontal status and bacteremia with oral viridans streptococci and coagulase negative staphylococci in allogeneic hematopoietic stem cell transplantation recipients: a prospective observational study.

Authors:  Judith E Raber-Durlacher; Alexa M G A Laheij; Joel B Epstein; Matthew Epstein; Gerard M Geerligs; Gordon N Wolffe; Nicole M A Blijlevens; J Peter Donnelly
Journal:  Support Care Cancer       Date:  2013-01-04       Impact factor: 3.603

7.  In vitro activities of iodonium salts against oral and dental anaerobes.

Authors:  Ellie J C Goldstein; Diane M Citron; Yumi Warren; C Vreni Merriam; Kerin Tyrrell; Helen Fernandez; Ukkiramapandian Radhakrishnan; Peter J Stang; Georg Conrads
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

8.  Oral microbiota and cancer.

Authors:  Jukka H Meurman
Journal:  J Oral Microbiol       Date:  2010-08-10       Impact factor: 5.474

9.  Evaluation of Antibacterial Effectiveness of Desensitizers against Oral Bacteria.

Authors:  Ismet Duran; Abdulkadir Sengun; Hasan Huseyin Hadimli; Mustafa Ulker
Journal:  Eur J Dent       Date:  2008-01

10.  Antiplaque and antigingivitis effects of a mouthrinse containing cetylpyridinium chloride, triclosan and dipotassium glycyrrhizinate.

Authors:  Jae-Yong Shim; Sung-Bin Yim; Jin-Hyung Chung; Ki Seok Hong
Journal:  J Periodontal Implant Sci       Date:  2012-04-30       Impact factor: 2.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.